spacer
home > ict > summer 2007 > appointment at the eclinic
PUBLICATIONS
International Clinical Trials

Appointment at the eClinic

Is it merely a matter of time before eClinical solutions are delivering value across the pharmaceutical drug development process? David Laky of eResearchTechnology, Inc, reports

Drug development is an intensely competitive process, and organisations equipped with the best strategy will ultimately take first prize. First prize in this industry is often synonymous with ‘first-to-market’ status, translating into millions of dollars in revenue. Recent breakthroughs offer organisations (be it sponsors, CROs or SMOs) who are conducting or supporting research an equal opportunity to achieve this goal by leveraging technology and managing clinical trials more efficiently through eClinical solutions. An eClinical solution delivers the results originally anticipated from electronic data capture (EDC) by linking sponsors, CROs, physicians and patients into a fully integrated management platform right through the clinical trial.

TRADITIONAL EDC DEFINED

EDC originated from remote data entry software, which developed applications in the life science industry during the late 1980s and early 1990s. As a clinical research tool, EDC promised tremendous advantages over the historically paper process of capturing clinical trial data. Through EDC, data is collected (either electronically or manually) and entered at the respective investigative sites, which greatly reduces subsequent data issues. Once entered, data is subjected to a series of front-end data entry checks. These checks identify and filter out potential errors, thereby limiting the expensive process of correcting data after the site work is completed. Most importantly, EDC provides rapid access to data, enabling sponsoring organisations to begin the process of analysing results, identifying any adverse trends and making critical decisions regarding the potential efficacy of the drug being tested.

There is no disputing that EDC provides real-time access to more accurate data. It also shortens the clinical trial timeframe, automatically generating some level of cost savings. In fact, some industry executives claim EDC has enabled them to reduce 70 to 80 per cent of data errors, going from the investigative site to the sponsoring organisation (1).


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
4
     

There are no comments in regards to this article.

spacer
David Laky has more than 15 years’ experience implementing technology solutions across various and diverse industries. For the last seven years, he has been with eResearchTechnology, and currently serves as Vice President and General Manager of the Clinical Data Applications group. Dave graduated with a BSc in Accounting and a Minor in Economics from Pennsylvania State University.
spacer
David Laky
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Wool packaging firm’s green scheme goes ‘beyond recycling’

An award-winning company that has spent more than 10 years innovating in sustainable packaging has launched a scheme that it says goes ‘beyond recycling’ – by allowing the end user to return their packaging directly to them to be used again.
More info >>

White Papers

Keeping Abreast of the Competitive Environment in Clinical Development

Thomson Reuters

Strategic management of a therapy area requires hard decisions to be made about which programs to invest in and which to let go. Understanding the rapidly changing competitive environment for your drug candidates is a key input into these decisions. It is easy to lose track of the broader picture when a clinical program is in progress and get blindsided by external events.
More info >>

 
Industry Events

SCOPE Europe – Summit for Clinical Ops Executives Europe

17-18 September 2019, Barcelona, Spain

Building on the success of its long-running US-based counterpart, Summit for Clinical Trials Operations Executives Europe (SCOPE Europe) is a two-day event serving clinical innovation leaders, clin ops execs, functional heads, category managers, and those responsible for the planning and management of clinical trials in Europe and the Rest of the World. The event will feature opening and closing plenary keynote sessions, five conference tracks, interactive breakout discussion groups, and networking. It is an opportunity for leaders from large, mid-sized, and small pharma, specialty pharma, biotech, vendor companies, and academic research centers to come together to share best practices and discuss the new era of analytics-driven and patient-centric trials.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement